SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-17-020879
Filing Date
2017-12-19
Accepted
2017-12-19 09:02:42
Documents
28
Period of Report
2017-12-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20171218_8k.htm 8-K 32503
2 EXHIBIT 99.1 ex_102280.htm EX-99.1 16558
3 a26.jpg GRAPHIC 138213
4 a25.jpg GRAPHIC 119595
5 a24.jpg GRAPHIC 139035
6 a23.jpg GRAPHIC 125759
7 a22.jpg GRAPHIC 115005
8 a21.jpg GRAPHIC 142901
9 a20.jpg GRAPHIC 82046
10 a19.jpg GRAPHIC 86921
11 a18.jpg GRAPHIC 121846
12 a17.jpg GRAPHIC 138325
13 a16.jpg GRAPHIC 98633
14 a15.jpg GRAPHIC 156328
15 a14.jpg GRAPHIC 98382
16 a13.jpg GRAPHIC 124925
17 a12.jpg GRAPHIC 100518
18 a11.jpg GRAPHIC 161517
19 a10.jpg GRAPHIC 120344
20 a09.jpg GRAPHIC 128480
21 a08.jpg GRAPHIC 142273
22 a07.jpg GRAPHIC 113383
23 a06.jpg GRAPHIC 91853
24 a05.jpg GRAPHIC 157685
25 a04.jpg GRAPHIC 112613
26 a03.jpg GRAPHIC 227050
27 a02.jpg GRAPHIC 199947
28 a01.jpg GRAPHIC 69419
  Complete submission text file 0001437749-17-020879.txt   4615158
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 171262879
SIC: 2836 Biological Products, (No Diagnostic Substances)